• Genomics & Informatics
• /
• v.5 no.3
• /
• pp.129-132
• /
• 2007

arraylmpute is a software for exploratory analysis of missing data and imputation of missing values in microarray data. It also provides a comparative analysis of the imputed values obtained from various imputation methods. Thus, it allows the users to choose an appropriate imputation method for microarray data. It is built on R and provides a user-friendly graphical interface. Therefore, the users can easily use arraylmpute to explore, estimate missing data, and compare imputation methods for further analysis.

• Journal of Information Processing Systems
• /
• v.14 no.5
• /
• pp.1167-1175
• /
• 2018

Microarray data plays an essential role in diagnosing and detecting cancer. Microarray analysis allows the examination of levels of gene expression in specific cell samples, where thousands of genes can be analyzed simultaneously. However, microarray data have very little sample data and high data dimensionality. Therefore, to classify microarray data, a dimensional reduction process is required. Dimensional reduction can eliminate redundancy of data; thus, features used in classification are features that only have a high correlation with their class. There are two types of dimensional reduction, namely feature selection and feature extraction. In this paper, we used k-means algorithm as the clustering approach for feature selection. The proposed approach can be used to categorize features that have the same characteristics in one cluster, so that redundancy in microarray data is removed. The result of clustering is ranked using the Relief algorithm such that the best scoring element for each cluster is obtained. All best elements of each cluster are selected and used as features in the classification process. Next, the Random Forest algorithm is used. Based on the simulation, the accuracy of the proposed approach for each dataset, namely Colon, Lung Cancer, and Prostate Tumor, achieved 85.87%, 98.9%, and 89% accuracy, respectively. The accuracy of the proposed approach is therefore higher than the approach using Random Forest without clustering.

• Journal of KIISE:Software and Applications
• /
• v.29 no.11
• /
• pp.775-784
• /
• 2002

Microarray data, obtained from DNA chip technologies, is the measurement of the expression level of thousands of genes in cells or tissues. It is used for gene function prediction or cancer diagnosis based on gene expression patterns. Among diverse methods for data analysis, the Bayesian network represents the relationships among data attributes in the form of a graph structure. This property enables us to discover various relations among genes and the characteristics of the tissue (e.g., the cancer type) through microarray data analysis. However, most of the present microarray data sets are so sparse that it is difficult to apply general analysis methods, including Bayesian networks, directly. In this paper, we harness an efficient structural learning algorithm and data dimensionality reduction in order to analyze microarray data using Bayesian networks. The proposed method was applied to the analysis of real microarray data, i.e., the NC160 data set. And its usefulness was evaluated based on the accuracy of the teamed Bayesian networks on representing the known biological facts.

• Molecules and Cells
• /
• v.25 no.2
• /
• pp.279-288
• /
• 2008

The analysis of microarray data is essential for large amounts of gene expression data. In this review we focus on clustering techniques. The biological rationale for this approach is the fact that many co-expressed genes are co-regulated, and identifying co-expressed genes could aid in functional annotation of novel genes, de novo identification of transcription factor binding sites and elucidation of complex biological pathways. Co-expressed genes are usually identified in microarray experiments by clustering techniques. There are many such methods, and the results obtained even for the same datasets may vary considerably depending on the algorithms and metrics for dissimilarity measures used, as well as on user-selectable parameters such as desired number of clusters and initial values. Therefore, biologists who want to interpret microarray data should be aware of the weakness and strengths of the clustering methods used. In this review, we survey the basic principles of clustering of DNA microarray data from crisp clustering algorithms such as hierarchical clustering, K-means and self-organizing maps, to complex clustering algorithms like fuzzy clustering.

• Proceedings of the Korean Statistical Society Conference
• /
• 2005.11a
• /
• pp.37-41
• /
• 2005

Exploratory data analysis(EDA) is the initial stage of data analysis and provides a useful overview about the whole microarray experiment. If the experiments are replicated, the analyst should check the quality and reliability of microarray data within same experimental condition before the deeper statistical analysis. We shows EDA method focusing on the quality and reproducibility for replicates.

• Proceedings of the Korean Society for Bioinformatics Conference
• /
• 2006.02a
• /
• pp.30-36
• /
• 2006

Tissue microarray (TMA) is an array-based technology allowing the examination of hundreds of tissue samples on a single slide. To handle, exchange, and disseminate TMA data, we need standard representations of the methods used, of the data generated, and of the clinical and histopathological information related to TMA data analysis. This study aims to create a comprehensive data model with flexibility that supports diverse experimental designs and with expressivity and extensibility that enables an adequate and comprehensive description of new clinical and histopathological data elements. We designed a Tissue Microarray Object Model (TMA-OM). Both the Array Information and the Experimental Procedure models are created by referring to Microarray Gene Expression Object Model, Minimum Information Specification For In Situ Hybridization and Immunohistochemistry Experiments (MISFISHIE), and the TMA Data Exchange Specifications (TMA DES). The Clinical and Histopathological Information model is created by using CAP Cancer Protocols and National Cancer Institute Common Data Elements (NCI CDEs). MGED Ontology, UMLS and the terms extracted from CAP Cancer Protocols and NCI CDEs are used to create a controlled vocabulary for unambiguous annotation. We implemented a web-based application for TMA-OM, supporting data export in XML format conforming to the TMA DES or the DTD derived from TMA-OM. TMA-OM provides a comprehensive data model for storage, analysis and exchange of TMA data and facilitates model-level integration of other biological models.

• Journal of Institute of Control, Robotics and Systems
• /
• v.11 no.10
• /
• pp.830-836
• /
• 2005

Application of microarray technologies which monitor simultaneously the expression pattern of thousands of individual genes in different biological systems results in a tremendous increase of the amount of available gene expression data and have provided new insights into gene expression during drug development, within disease processes, and across species. There is a great need of data mining methods allowing straightforward interpretation, visualization and analysis of the relevant information contained in gene expression profiles. Specially, classifying biological samples into known classes or phenotypes is an important practical application for microarray gene expression profiles. Gene expression profiles obtained from tissue samples of patients thus allowcancer classification. In this research, molecular classification of microarray gene expression data is applied for multi-class cancer using computational biology such gene selection, principal component analysis and fuzzy clustering. The proposed method was applied to microarray data from leukemia patients; specifically, it was used to interpret the gene expression pattern and analyze the leukemia subtype whose expression profiles correlated with four cases of acute leukemia gene expression. A basic understanding of the microarray data analysis is also introduced.

• The Korean Journal of Applied Statistics
• /
• v.17 no.3
• /
• pp.419-430
• /
• 2004

Since cDNA microarray experiments can monitor expression levels for thousands of genes simultaneously, the experimental designs and their analyzing methods are very important for successful analysis of microarray data. The loop design is discussed for selecting differentially expressed genes among several treatments and the analysis of variance method is introduced to normalize microarray data and provide estimates of the interesting quantities. MA-ANOVA is used to illustrate this method on a recently collected loop designed microarray data at Cancer Metastasis Research Center, Yonsei University.

• The Korean Journal of Applied Statistics
• /
• v.22 no.1
• /
• pp.89-106
• /
• 2009

There have been many new advances in the development of improved clustering methods for microarray data analysis, but traditional clustering methods are still often used in genomic data analysis, which maY be more due to their conceptual simplicity and their broad usability in commercial software packages than to their intrinsic merits. Thus, it is crucial to assess the performance of each existing method through a comprehensive comparative analysis so as to provide informed guidelines on choosing clustering methods. In this study, we investigated existing clustering methods applied to microarray data in various real scenarios. To this end, we focused on how the various methods differ, and why a particular method does not perform well. We applied both internal and external validation methods to the following eight clustering methods using various simulated data sets and real microarray data sets.

• Proceedings of the Korean Society for Bioinformatics Conference
• /
• 2005.09a
• /
• pp.29-34
• /
• 2005

DNA microarray becomes a major tool for the investigation of global gene expression in all aspects of cancer and biomedical research. DNA microarray experiment generates enormous amounts of data and they are meaningful only in the context of a detailed description of microarrays, biomaterials, and conditions under which they were generated. MicroArray Gene Expression Data (MGED) society has established microarray standard for structured management of these diverse and large amount data. MGED MAGE-OM (MicroArray Gene Expression Object Model) is an object oriented data model, which attempts to define standard objects for gene expression. To assess the relevance of DNA microarray analysis of cancer research it is required to combine clinical and genomics data. MAGE-OM, however, does not have an appropriate structure to describe clinical information of cancer. For systematic integration of gene expression and clinical data, we create a new model, Cancer Genomics Object Model.